China’s Sinopharm Booster Vaccine Found Weaker Against Omicron Variant of COVID-19: Study
The study included 292 healthcare workers who had administered a third homologous boosting vaccination eight to nine months after completion of the priming two-dose inactivated vaccination. �� China’s Sinopharm Booster Vaccine Found Weaker Against Omicron Variant of COVID-19: Study.